Biological Safety Testing Products and Services Market

The biological safety testing market encompasses products like reagents and instruments, as well as services used to ensure the safety of pharmaceutical and biological products. Key customers include pharmaceutical companies, researchers, and government agencies involved in the development of new medicines. Market growth is primarily driven by rising innovation in new therapies like cell and gene therapy, increased investment in the healthcare industry, and the enforcement of stringent government safety regulations.

CAGR

12.9%

Compound Annual Growth Rate

Current Value

$7.50B

Estimated 2026

Projected Value

$19.8B

By 2034